8-K
Current Report
Ultragenyx Pharmaceutical Inc. Filed Acc 0001564590-18-022207
Benefit plan blackout
- Item 5.04 Temporary suspension of trading under employee benefit plans
From the SEC's structured data for this filing
Loading rare-8k_20180822.htm…